Search alternatives:
significantly slight » significantly lighter (Expand Search), significantly high (Expand Search), significantly higher (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
slight decrease » slight increase (Expand Search)
significantly slight » significantly lighter (Expand Search), significantly high (Expand Search), significantly higher (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
slight decrease » slight increase (Expand Search)
-
2161
-
2162
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2163
-
2164
-
2165
-
2166
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2167
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2168
-
2169
-
2170
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2171
-
2172
-
2173
-
2174
-
2175
-
2176
-
2177
-
2178
-
2179
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
2180